CAROLYN M TASTAD
CIK 1597938 · CEO - Health Care · last filed 2025-12-11
CAROLYN M TASTAD is a CEO - Health Care who has filed 87 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing shows the insider disposed of $2.4M of K on Dec 11, 2025. Across all open-market trades the lifetime net is −$46.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.2M across reported positions. 22 SEC filings were submitted jointly with KELLANOVA.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.22M
2
87
-$46.77M
Filer Profile
CINCINNATI, OH 45202
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KELLANOVA (K) Delisted | Director | 0 | $83.44 | $0 | $0 | 12 | 2025-12-11 |
| PG | CEO - Health Care | 28,823 | $146.44 | $4.22M | -$46.77M | 75 | 2022-03-03 |
Recent Filings
87 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-11 | KELLANOVA (K) Delisted | Disp (D) | −29,302 | -$2.45M | EDGAR |
| 2025-05-07 | KELLANOVA (K) Delisted | Grant (A) | +2,119 | $175.1K | EDGAR |
| 2024-05-07 | KELLANOVA (K) Delisted | Grant (A) | +2,915 | $175.0K | EDGAR |
| 2023-07-12 | KELLANOVA (K) Delisted | Grant (A) | +2,180 | $0 | EDGAR |
| 2023-05-10 | KELLANOVA (K) Delisted | Grant (A) | +2,080 | $0 | EDGAR |
| 2022-05-10 | KELLANOVA (K) Delisted | Grant (A) | +2,080 | $0 | EDGAR |
| 2022-03-03 | PG | Mixed | −3,730 | -$572.6K | EDGAR |
| 2021-12-07 | PG | Mixed | −212 | -$31.6K | EDGAR |
| 2021-10-05 | PG | Grant (A) | +3,251 | $0 | EDGAR |
| 2021-09-16 | PG | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.